Comparison of efficacy profiles for minimum lethal concentrations (MLCs) of some commonly used commercial hospital microbicidal detergent-disinfectant products for disinfectants and sporicidal activity.
AbstractIn an effort to evaluate and control the potential hazard and inherent risk of environmental transmission and spread of nosocomial infections by contact with hitherto “non-critical” inanimate/environmental surfaces in the hospital/ healthcare facilities (commode, bed, bowl of toilet etc.), the microbicidal efficacies of six disinfectants products of the most commonly used commercially available detergent-disinfectants (one chlorine-based, one phenol-based, two quaternary ammonium compounds (QACs), generation 3 and generation 4 and, two hydrogen peroxide-based) were evaluated at different concentrations using use-dilution method for evaluating the minimum lethal concentrations (MLCs). Results from these in vitro germicidal exposure experiments indicate that all six disinfectants tested were at the MLCs of these disinfectants in proportion to the recommended strengths varied significantly and yielded very different performance values for different test strains. This knowledge could prove to be of significance in assessing the risks associated with the use, and the incidental failure thereof, of different disinfectants used in the healthcare facilities. The results from our study highlights differences in the activity of germicides against different bacterial strains and indicate that the choice of disinfectant agents and the hospital decontamination protocols can markedly affect the prevalence and environmental distribution of pathogens, and that this could be, to a certain extent, better managed if a proper assessment of the risk associated with the use of disinfectants at off-recommended strengths conditions is taken into account in providing guidance towards and seeking satisfactory resolutions to the incidence of breach of manufacturers’ recommendations.
Copyright conditions: Copyright on any research article in the International Journal of Infection Control (IJIC) is retained by the author(s). Authors grant IJIC permission to publish the article and identify itself as the original publisher. Authors also grant any third party the right to use the article freely as long as its integrity is maintained and its original authors, citation details and publisher are identified. IJIC conforms to the Creative Commons Attribution License (http://creativecommons.org) as terms and conditions of publishing research articles. In summary, anyone is free: • to copy, distribute, and display the work; • to make derivative works; • to make commercial use of the work; as long as: • the original author must be given credit; • for any reuse or distribution, it must be made clear to others what the license terms of this work are; • any of these conditions can be waived if the authors gives permission. Statutory fair use and other rights are in no way affected by the above. Authors' certification: In submitting a manuscript to IJIC, authors are requested to certify that: • They are authorized by their co-authors to enter into these arrangements. • They warrant, on behalf of themselves and their co-authors, that: o the article is original, has not been formally published in any other peer-reviewed journal, is not under consideration by any other journal and does not infringe any existing copyright or any other third party rights; o they are the sole author(s) of the article and have full authority to enter into this agreement and in granting rights to IJIC are not in breach of any other obligation. If the law requires that the article be published in the public domain, they will notify IJIC at the time of submission; o the article contains nothing that is unlawful, libellous, or which would, if published, constitute a breach of contract or of confidence or of commitment given to secrecy; o they have taken due care to ensure the integrity of the article.